News

latest corporate presentation

Latest Summary Corporate Presentation

November 2023

View Presentation
18 Oct 2023 Actinogen Latest Summary Corporate Presentation October 2023
06 Oct 2023 Actinogen Company Presentation: ACW CEO presents to Dementia Trials Australia conference
29 Sep 2023 Actinogen Company Presentation: ACW Clinical Scientist presents to the Asian Society Against Dementia congress
14 Sep 2023 Actinogen Video interview: [14.46 mins] Xanamem program update
31 Aug 2023 Media Webcast video recording: Actinogen neuroscience webinar
24 May 2023 Actinogen Webcast video recording: Actinogen Clinical Trials Science Forum 2023
30 Mar 2023 Actinogen Oral presentation: CMO presentation at Alzheimer’s and Parkinson’s Disease Conference (AD/PD™) in Gothenburg, Sweden
24 Feb 2023 Actinogen Company presentation: Spark Plus Biotech Conference in Singapore
09 Jan 2023 Actinogen Company presentation: Sachs Neuroscience Innovation Forum and other meetings during the JP Morgan Healthcare Conference week
03 Dec 2022 Actinogen Poster presentation: CTAD conference 2022
16 Nov 2022 Actinogen Webcast video recording: AGM 16 Nov 2022 ACW Chair’s Address and CEO presentation
16 Nov 2022 Actinogen Company presentation: AGM 16 Nov 2022 ACW Chair’s Address and CEO presentation
09 Nov 2022 Bell Potter Webcast video recording: CEO presentation to Bell Potter Healthcare Conference 2022
09 Nov 2022 Actinogen Company presentation: CEO presentation to Bell Potter Healthcare Conference 2022
03 Nov 2022 SparkPlus Webinar video recording: CEO presentation at Spark Plus Healthcare Day
03 Nov 2022 Actinogen Company presentation: CEO presentation to Spark Plus Healthcare Day
24 Oct 2022 ShareCafe Webinar video recording: CEO presentation at ShareCafe “Hidden Gems”
21 Oct 2022 Actinogen Company presentation: CEO presentation at ShareCafe “Hidden Gems”
10 Oct 2022 Actinogen Webcast video recording: Alzheimer’s Disease biomarker study clinical results – Large clinical benefit on FDA-approved measurement of cognition and function in patients with Alzheimer’s Disease
10 Oct 2022 Actinogen Company presentation: Alzheimer’s Disease biomarker study clinical results – Large clinical benefit on FDA-approved measurement of cognition and function in patients with Alzheimer’s Disease
13 Sep 2022 Actinogen Company presentation: Xanamem® Clinical Program Update – Alzheimer’s Disease (AD) biomarkers – context and history
11 Aug 2022 Actinogen Company presentation: CEO presentation for non-deal roadshow investor meetings
03 Aug 2022 Actinogen Webcast video recording: Actinogen Clinical Trials Science Forum
03 Aug 2022 Actinogen Company presentation: Actinogen Clinical Trials Science Forum
28 Jul 2022 Actinogen Company presentation: CEO presentation to Spark Plus Australian Equities Day
14 Jun 2022 Actinogen Company presentation: CEO presentation for meetings at BIO International Convention
11 May 2022 Actinogen Company presentation: Bioshares Biotech Summit 2022
04 May 2022 Actinogen Company presentation: ACW trial results & strategic update presentation
27 Apr 2022 Actinogen Webcast video recording: XanaMIA Part A Trial positive topline results for Xanamem
27 Apr 2022 Actinogen Company presentation: XanaMIA Part A Trial positive topline results for Xanamem
01 Mar 2022 Actinogen Company presentation: CEO presents at Sachs 15th Annual European Life Sciences Conference
10 Jan 2022 Actinogen Company presentation: CEO presents at San Francisco Healthcare Conference
25 Nov 2021 Actinogen Webcast video recording: Strategic Update and Capital Raising Investor Presentation
25 Nov 2021 Actinogen Company presentation: Strategic Update & Capital Raising Investor Presentation
10 Nov 2021 Actinogen Webcast video recording: AGM 10 Nov 2021 ACW Chair’s Address and CEO presentation
10 Nov 2021 Actinogen Company presentation: AGM 10 Nov 2021 ACW Chair’s Address and CEO presentation
01 Oct 2021 Actinogen Company presentation: CEO presentation at conference call on 19 Oct 2021
10 Jun 2021 Actinogen Company presentation: BIO Digital 2021 (10-11 & 14-18 June 2021)
30 Apr 2021 Actinogen Teleconference call transcript: Strategic Update and Investor Presentation
21 Apr 2021 Actinogen Company presentation: Strategic Update and Investor Presentation
27 Nov 2020 Open Briefing Webcast video recording: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
27 Nov 2020 Actinogen Audio recording: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
27 Nov 2020 Actinogen Company presentation: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
02 Nov 2020 Actinogen Company presentation: New clinical development opportunity Fragile X syndrome
28 Oct 2020 Actinogen Company presentation: Monsoon Morning Twilight Investor Briefing
19 Oct 2020 Actinogen Webcast video recording: Conference Call 19 Oct 2020
08 Sep 2020 ASX Webcast video recording: CEO presentation at ASX Small & Mid-Cap Conference (8-10 Sep 2020)
08 Sep 2020 Actinogen Company investor presentation: ASX Small & Mid-Cap Conference (8-10 Sep 2020)
31 Jul 2020 Actinogen Poster presentation: Alzheimer’s Association International Conference (AAIC) Virtual Event (27-31 Jul 2020) Poster presentation by Prof Craig Ritchie, Chair of Actinogen Xanamem Clinical Advisory Board on behalf of Actinogen “Drug Development Summary for Xanamem™, a Potent Inhibitor of the 11β-HSD1 Enzyme”
31 Jul 2020 Finance News Network Webcast video recording: CEO presentation to FNN CEO Showcase – FNN Online Investor Event, July 2020
15 Jul 2020 Actinogen Webcast video recording: CEO presentation at Bio Digital 2020
08 Jun 2020 Actinogen Company presentation: CEO presentation at Bio Digital 2020
08 Jun 2020 Actinogen Company presentation: CEO presentation for partnering meetings at BIO Digital 2020
29 Apr 2020 Actinogen Webcast video recording: Prof Craig Ritchie, Chair of ACW’s Xanamem Clinical Advisory Board presentation at AAT/AD-PD 2020
29 Apr 2020 Actinogen Company presentation summary: AAT-AD/PD 2020
29 Apr 2020 Actinogen Company presentation: Prof Craig Ritchie, Chair of ACW’s Xanamem Clinical Advisory Board presentation at AAT/AD-PD 2020
29 Jan 2020 Sachs TV Webcast video recording: CEO presentation at SACHS Neuroscience Innovation Forum in San Francisco, USA
08 Jan 2020 Actinogen Company presentation: CEO presentation at SACHS Neuroscience Innovation Forum and partnering meetings during JPM week
25 Nov 2019 Actinogen Webcast video recording: AGM 2019 ACW Managing Directors Address to Shareholders
25 Nov 2019 Actinogen Company presentation: AGM 2019 Managing Director’s Address to Shareholders
06 Nov 2019 Small Caps Webcast video recording: CEO presentation at Australian Microcap Investment Conference 2019
25 Sep 2019 Actinogen Poster presentation: AAIC Satellite Symposium
26 Jun 2019 Actinogen Company investor presentation: A novel approach to treating cognitive impairment and Alzheimer’s disease
01 May 2019 Actinogen Company investor presentation: May 2019
21 Mar 2019 Actinogen Company investor presentation: Mar 2019
07 Jan 2019 Actinogen Company presentation: ACW presents at SACHS Neuroscience Innovation Forum during JPM Week
06 Jan 2019 Sachs TV Webcast video recording: CEO presentation at 2nd Annual SACHS Neuroscience Innovation Forum
28 Nov 2018 Actinogen Company presentation: AGM 28 Nov 2018 ACW Managing Director’s presentation
26 Nov 2018 Actinogen Company investor presentation: A novel approach to treating cognitive impairment and Alzheimer’s disease
30 Oct 2018 Actinogen Company presentation: CEO presentation at Australia Biotech Invest & Partnering 2018
17 Oct 2018 Actinogen Company presentation: CEO presentation at Australian Microcap Investment Conference
25 Sep 2018 FNN Investor Event Webcast video recording: CEO presentation at FNN investor event – ACW Phase II Alzheimer’s trials
12 Sep 2018 Actinogen Company presentation: CEO presentation at Singapore Healthcare Investor Day Sep 2018
04 Jun 2018 Actinogen Company presentation: Presentation at BIO International Convention
30 May 2018 Open Briefing Teleconference call transcript: Investor Conference Call
30 May 2018 Actinogen Audio recording: Investor Conference Call
28 May 2018 Actinogen Company investor presentation: May/Jun 2018
05 Apr 2018 Actinogen Webcast video recording: Investor Open Briefing March 2018
19 Mar 2018 Actinogen Medical Company presentation: Investor Open Briefing Mar 2018: Alzheimer Treatment Needs a New Approach – Xanamem
29 Nov 2017 Actinogen Company presentation: AGM 29 Nov 2017 ACW Managing Director’s presentation
16 Oct 2017 Actinogen Company investor presentation: Oct 2017
27 Mar 2017 Actinogen Company investor presentation: March 2017

Back
to top